SilverBow Resources Announces Upsize and Pricing of Secondary Offering of Common Stock
HOUSTON–(BUSINESS WIRE)–SilverBow Resources, Inc. (NYSE: SBOW) (“SilverBow” or the “Company”) today announced the upsize and pricing of a previously... Read more.
SPECIAL REPORT: Even as Inflation Drops, Financial Challenges Remain for Middle-Income Families
Compounding impact of inflation has resulted in average cumulative household budget deficit of nearly $2,500 since May 2021 DULUTH, Ga.–(BUSINESS WIRE)–Primerica,... Read more.
Eaton’s heavy-duty four-speed electric vehicle transmission receives prestigious award from top China-based automotive publication
SOUTHFIELD, Mich.–(BUSINESS WIRE)–#autosupplier–Intelligent power management company Eaton today announced it has received the “2023 Top 100... Read more.
Kinetik Announces Pricing of Upsized Secondary Offering of Common Stock
HOUSTON & MIDLAND, Texas–(BUSINESS WIRE)–Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced today the pricing of an... Read more.
L&T Technology Services and bp Sign Multi-Year Engineering Services Partnership
Landmark Deal sees LTTS and bp partner in Projects, Operations, Maintenance and Low carbon initiatives HOUSTON & BANGALORE, India–(BUSINESS WIRE)–$LTTS... Read more.
Two Early Studies Evaluating Potential First-in-Class CELMoD™ Agent Golcadomide for the Treatment of Non-Hodgkin Lymphomas Presented at ASH 2023
Phase 1b DLBCL-001 study reinforces promising activity and combinability of golcadomide with R-CHOP in patients with previously untreated aggressive B-cell lymphoma... Read more.
Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH
–Preclinical data for Cimeio’s CD45 universal heme ADC and shielded HSCs demonstrate effective depletion of an aggressive AML cell line in vivo– –First... Read more.
Analyses of Kite’s Yescarta® CAR T-Cell Therapy Support Curative Potential in Patients With Non-Hodgkin Lymphomas
– ZUMA-1 Post-Hoc Analysis Shows Five-Year Lymphoma-Related Event-Free Survival in a Substantial Proportion of Patients with Refractory Large B-cell Lymphoma –... Read more.
The Law Offices of Frank R. Cruz Announces Investigation of General Motors Company (GM) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of General Motors Company (“GM” or the “Company”) (NYSE:... Read more.
The Law Offices of Frank R. Cruz Announces Investigation of General Motors Company (GM) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of General Motors Company (“GM” or the “Company”) (NYSE:... Read more.